A low blood count or anaemia can lead to tiredness and breathlessness. This is may be due to loss of blood from the gut (especially if there is evidence of low body iron stores)...

Article

Extended funding for adalimumab (Humira)

Adalimumab is now available for Crohn's disease with fistula formation. This is a severe and disabling complication of Crohn's disease. Often patients with this problem could be funded based on other criteria. However having a complicated or significant fistula is now enough to justify funding for adalimumab. Treatment will need to be for several years as fistulas can be slow to respond

designed and developed by QT Web